These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15728834)

  • 1. Antiepileptic effects of botulinum neurotoxin E.
    Costantin L; Bozzi Y; Richichi C; Viegi A; Antonucci F; Funicello M; Gobbi M; Mennini T; Rossetto O; Montecucco C; Maffei L; Vezzani A; Caleo M
    J Neurosci; 2005 Feb; 25(8):1943-51. PubMed ID: 15728834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat.
    Bröer S; Zolkowska D; Gernert M; Rogawski MA
    Neuroscience; 2013 Nov; 252():253-61. PubMed ID: 23906638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute neuroprotection by the synaptic blocker botulinum neurotoxin E in a rat model of focal cerebral ischaemia.
    Antonucci F; Cerri C; Maya Vetencourt JF; Caleo M
    Neuroscience; 2010 Aug; 169(1):395-401. PubMed ID: 20447449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A).
    Restani L; Antonucci F; Gianfranceschi L; Rossi C; Rossetto O; Caleo M
    J Neurosci; 2011 Nov; 31(44):15650-9. PubMed ID: 22049408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
    Apland JP; Adler M; Oyler GA
    J Protein Chem; 2003 Feb; 22(2):147-53. PubMed ID: 12760419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy.
    Antonucci F; Di Garbo A; Novelli E; Manno I; Sartucci F; Bozzi Y; Caleo M
    Exp Neurol; 2008 Apr; 210(2):388-401. PubMed ID: 18177862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahippocampal infusion of botulinum neurotoxin E (BoNT/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy.
    Antonucci F; Bozzi Y; Caleo M
    Epilepsia; 2009 Apr; 50(4):963-6. PubMed ID: 19175393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
    Adler M; Keller JE; Sheridan RE; Deshpande SS
    Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK; Singh BR
    Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE; Cai F; Neale EA
    Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus.
    Manno I; Antonucci F; Caleo M; Bozzi Y
    Neuroreport; 2007 Mar; 18(4):373-6. PubMed ID: 17441289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
    Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
    Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus.
    Manno I; Antonucci F; Caleo M; Bozzi Y
    Neuroreport; 2007 Apr; 18(6):577-80. PubMed ID: 17413660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
    Lawrence GW; Foran P; Dolly JO
    Eur J Biochem; 1996 Mar; 236(3):877-86. PubMed ID: 8665909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
    Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
    Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
    Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats.
    Gasior M; Tang R; Rogawski MA
    J Pharmacol Exp Ther; 2013 Sep; 346(3):528-34. PubMed ID: 23772062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
    Keller JE; Neale EA
    J Biol Chem; 2001 Apr; 276(16):13476-82. PubMed ID: 11278807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
    J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility to hippocampal and amygdala kindling following intrahippocampal kainic acid.
    Feldblum S; Ackermann RF
    Exp Neurol; 1987 Aug; 97(2):255-69. PubMed ID: 3609210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.